Our Services
Medical Information
Helpful Resources
Published on: 9/23/2026
Updated 2024-2025 COVID vaccines targeting the JN.1 and KP.2 lineages continue to offer strong protection against severe illness, hospitalization, and death from currently circulating Omicron descendants, though protection against mild infection is more modest and wanes within about 4 to 6 months. Effectiveness varies by age, immune status, prior infection, and how long ago you were vaccinated, so there are several important factors to consider before deciding on a booster. See below to understand more about how each variant responds, who benefits most from an additional dose, and what symptoms to watch for if you do get infected.
Because vaccinated people can still catch newer variants with milder or unusual symptoms that overlap with flu, RSV, and allergies, guessing what you have often leads to delayed care or unnecessary worry. A free, instant, online symptom check takes only a few minutes, helps you compare your symptoms against likely causes, and points you toward the right next step, whether that is testing, antivirals within the treatment window, or simply rest at home.
Last reviewed for medical accuracy: 09/23/2026
Understanding “covid vaccine effectiveness” can help you make informed decisions about your health. With new variants circulating, you might be wondering how well vaccines protect against infection, severe illness, and hospitalization. This article breaks down the latest data from credible sources such as the U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), explains what affects vaccine performance, and offers practical steps you can take.
Vaccine effectiveness (VE) measures how well a vaccine works in the real world. Key points include:
VE is usually expressed as a percentage. For example, a VE of 80% against hospitalization means vaccinated people have an 80% lower risk of ending up in the hospital compared to unvaccinated people.
Since Omicron first appeared, the virus has continued to evolve. Latest subvariants include BA.4, BA.5, BQ.1, XBB.1.5 and similar offshoots. Here’s what we know about vaccine performance against these strains:
Primary Series (Two Doses of mRNA or Equivalent):
First Booster (Three Doses Total):
Bivalent Booster (Targeting Omicron + Original Strain):
Several factors influence how well COVID vaccines protect you:
Waning Immunity
Antibody levels naturally decline over time. Boosters help restore high protection.
Variant Mutations
Newer variants can partially escape immunity from earlier vaccines, reducing VE modestly.
Age and Health Status
Older adults and people with weakened immune systems may have lower VE and may benefit from earlier or additional boosters.
Time Since Last Dose
The longer it’s been since your last shot, the more protection can drop, especially against infection.
Even with some decline in preventing infection, vaccines remain crucial:
Health authorities recommend staying current with boosters:
Discuss your specific situation with a doctor or pharmacist to determine the best schedule for you.
Vaccination is the foundation, but layering additional measures adds protection:
Even vaccinated people can get infected. If you notice symptoms such as fever, cough, shortness of breath, loss of taste or smell, or fatigue, you can do a quick risk check online. Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to guide your next steps.
If you test positive for COVID-19:
While most people recover at home, some signs require urgent attention. You should speak to a doctor or call emergency services if you experience:
Researchers continue to track new variants and update vaccines. Annual or seasonal COVID boosters could become the norm, similar to flu shots. Keeping up with guidance from health authorities ensures you have the best possible protection.
Staying informed and proactive will help you navigate COVID-19 with confidence and reduce your risk of severe outcomes. Remember, if you ever feel your health is in jeopardy, seek medical attention right away.
(References)
* Chatterjee B, Thakur SS. Diverse vaccine platforms safeguarding against SARS-CoV-2 and its variants. Expert Rev Vaccines. 2022 Jan;21(1):47-67. doi: 10.1080/14760584.2022.1997601. Epub 2022 Jan 11. PMID: 34697980; PMCID: PMC8787839.
* Hadj Hassine I. Covid-19 vaccines and variants of concern: A review. Rev Med Virol. 2022 Jul;32(4):e2313. doi: 10.1002/rmv.2313. Epub 2021 Nov 9. PMID: 34755408; PMCID: PMC8646685.
* Wang K, Jia Z, Bao L, Wang L, Cao L, Chi H, Hu Y, Li Q, Zhou Y, Jiang Y, Zhu Q, Deng Y, Liu P, Wang N, Wang L, Liu M, Li Y, Zhu B, Fan K, Fu W, Yang P, Pei X, Cui Z, Qin L, Ge P, Wu J, Liu S, Chen Y, Huang W, Wang Q, Qin CF, Wang Y, Qin C, Wang X. Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants. Nature. 2022 Mar;603(7903):919-925. doi: 10.1038/s41586-022-04466-x. Epub 2022 Jan 28. PMID: 35090164; PMCID: PMC8967717.
* Li C, Zhan W, Yang Z, Tu C, Hu G, Zhang X, Song W, Du S, Zhu Y, Huang K, Kong Y, Zhang M, Mao Q, Gu X, Zhang Y, Xie Y, Deng Q, Song Y, Chen Z, Lu L, Jiang S, Wu Y, Sun L, Ying T. Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody. Cell. 2022 Apr 14;185(8):1389-1401.e18. doi: 10.1016/j.cell.2022.03.009. Epub 2022 Mar 10. PMID: 35344711; PMCID: PMC8907017.
* Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T, Fan J, Song L, Tong Y, Fan H. COVID-19 vaccine development: milestones, lessons and prospects. Signal Transduct Target Ther. 2022 May 3;7(1):146. doi: 10.1038/s41392-022-00996-y. Epub 2022 May 3. PMID: 35504917; PMCID: PMC9062866.
* Branche AR, Rouphael NG, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Anderson EJ, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Malkin E, Bethony JM, Walsh EE, Graciaa DS, Samaha H, Sherman AC, Walsh SR, Abate G, Oikonomopoulou Z, El Sahly HM, Martin TCS, Kamidani S, Smith MJ, Ladner BG, Porterfield L, Dunstan M, Wald A, Davis T, Atmar RL, Mulligan MJ, Lyke KE, Posavad CM, Meagher MA, Stephens DS, Neuzil KM, Abebe K, Hill H, Albert J, Telu K, Mu J, Lewis TC, Giebeig LA, Eaton A, Netzl A, Wilks SH, Türeli S, Makhene M, Crandon S, Montefiori DC, Makowski M, Smith DJ, Nayak SU, Roberts PC, Beigel JH, COVAIL Study Group. Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial. Nat Med. 2023 Sep;29(9):2334-2346. doi: 10.1038/s41591-023-02503-4. Epub 2023 Aug 28. PMID: 37640860; PMCID: PMC10504073.
* Krammer F, Ellebedy AH. Variant-adapted COVID-19 booster vaccines. Science. 2023 Oct 13;382(6667):157-159. doi: 10.1126/science.adh2712. Epub 2023 Oct 12. PMID: 37824671.
* Yisimayi A, Song W, Wang J, Jian F, Yu Y, Chen X, Xu Y, Yang S, Niu X, Xiao T, Wang J, Zhao L, Sun H, An R, Zhang N, Wang Y, Wang P, Yu L, Lv Z, Gu Q, Shao F, Jin R, Shen Z, Xie XS, Wang Y, Cao Y. Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting. Nature. 2024 Jan;625(7993):148-156. doi: 10.1038/s41586-023-06753-7. Epub 2023 Nov 22. PMID: 37993710; PMCID: PMC10764275.
* Zhou G, Dael N, Verweij S, Balafas S, Mubarik S, Oude Rengerink K, Pasmooij AMG, van Baarle D, Mol PGM, de Bock GH, Hak E. Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024. Eur Respir Rev. 2025 Jan;34(175). doi: 10.1183/16000617.0222-2024. Epub 2025 Feb 19. PMID: 39971395; PMCID: PMC11836669.
* El-Akkad SE, Shao S, Tran KC, Naik H, Janjua N, Sbihi H, Carlsten C, Russell JA, Levin A, Wong AW. Association between COVID-19 vaccination, SARS-CoV-2 variants, and post COVID-19 condition: A cross-sectional study. PLoS One. 2025;20(12):e0336929. doi: 10.1371/journal.pone.0336929. Epub 2025 Dec 2. PMID: 41329751; PMCID: PMC12671788.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.